Louis W. Beardell Jr. focuses his practice on intellectual property (IP) matters in connection with patent strategies, IP due diligence, litigation, and transactions. He assists clients in developing and implementing programs that protect products and inventions including trade secrets, particularly in the life sciences, technology, and financial services fields. For US and international clients, Louis negotiates and prepares the IP aspects of licensing and purchase agreements, as well as agreements relating to product and service supply, collaboration, research, consulting, patent litigation settlement, and material transfer.
Louis counsels on all matters related to patent strategies, patent validity, patent due diligence, and freedom-to-operate opinions. His clients include an array of US and international companies in pharmaceuticals, chemicals, biotechnology, agricultural science, medical devices, and food science as well as major venture capital funds.
As companies evolve and modernize the way they operate, Louis ensures that they are able to establish exclusive positions to protect how they do business through procuring business method patents, as well as evaluating patent validity and freedom-to-operate positions for computer and business method inventions. His ability to prosecute patents and handle important trade secrets allows him to counsel clients through the creation of a diverse assortment of IP programs.
Louis frequently lecturers to academic institutions and professional organizations on a variety of IP topics. He has been hosted by US and international IP and business associations, as well as top law schools and business school IP and entrepreneur classes
Ranked, IAM Patent 1000—The World’s Leading Patent Professionals (2017)
Ranked, The Best Lawyers in America (2016–2018)
Ranked, The Legal 500 US (2016)
Recognized in Who’s Who Legal (2016)
Recognized as an "IP Star" by Managing IP guide published by Euromoney's Legal Media Group (2013, 2015–2016)
Member, Industry Advisory Board, National Brain Tumor Society (2013–present)
Member, American Intellectual Property Law Association
Member, Philadelphia Intellectual Property Law Association
Member, Licensing Executives Society
Member, Benjamin Franklin American Inn of Court, Philadelphia Intellectual Property Chapter
Member, Intellectual Property Owners Association
March 2018 - Morgan Lewis Among Juristat Top 100 Patent Firms in 2018
12/12/2017 - Morgan Lewis Advises Repros Therapeutics in Sale to Allergan
April 2017 - Morgan Lewis Recognized as a Top Patent Firm by Juristat
1/17/2017 - Morgan Lewis Advises Lovell Minnick Partners on Investment in Engage People, Inc.
March 2016 - Morgan Lewis Ranked as one of Juristat's Top 100 Patent Firms
9/22/2015 - Morgan Lewis Advises Portware, LLC in $265M Acquisition by FactSet Research Systems Inc.
8/3/2015 - Morgan Lewis Advises Foresight Biotherapeutics Inc. in Sale to Shire plc
7/22/2015 - Morgan Lewis Advises BlackBerry in its Acquisition of AtHoc
4/2/2015 - Morgan Lewis Advises Performance Fibers on Sale of Asia Operations
2/3/2015 - Morgan Lewis Advises FMC Corporation in $1.64 Billion Alkali Division Sale to Tronox Ltd.
12/4/2014 - Morgan Lewis Advises BTG in Acquisition of Medical Device Maker PneumRx
7/8/2014 - Morgan Lewis advises Gentex on acquisition of Helmet Integrated Systems Limited
5/22/2014 - Morgan Lewis Advises Agile Therapeutics on IPO
2/4/2014 - Morgan Lewis Advises Chiesi on Completed Cornerstone Acquisition
4/16/2012 - Morgan Lewis Advises Fanatics on Acquisition of Dreams for $183M
4/4/2012 - Morgan Lewis Advises Sun Capital on Acquisition of Certified Power
3/28/2011 - Morgan Lewis Advises GSI Commerce on $2.4 Billion Acquisition by eBay
2/9/2011 - Morgan Lewis Advises GSI in $277M Acquisition of Fanatics
Copyright © 2018 Morgan, Lewis & Bockius LLP. All rights reserved.